Brain-derived TNFα mediates neuropathic pain

Brain Research

Volumn 841, Issue 1-2, 1999, Pages 70-77

  Ignatowski, Tracey A ^a   Covey, William C ^a   Knight, Paul R ^a   Severin, Charles M ^b   Nickola, Tracey J ^a   Spengler, Robert N ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

2 Adrenergic receptor; Hippocampus; Microinfusion; Norepinephrine; Pain; TNF

Indexed keywords

NORADRENALIN; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HIPPOCAMPUS; HOT PLATE TEST; HYPERALGESIA; MALE; NERVE COMPRESSION; NERVE INJURY; NEUROPATHY; NOCICEPTION; NONHUMAN; NORADRENALIN RELEASE; NORADRENERGIC NERVE; PAIN; PAIN THRESHOLD; PRIORITY JOURNAL; RAT; ANIMAL; BIOASSAY; BIOSYNTHESIS; BRAIN; BRAIN VENTRICLE; CELL LINE; DRUG EFFECT; ELECTROSTIMULATION; HEAT; IN VITRO STUDY; INFUSION; METABOLISM; NEURITIS; PATHOPHYSIOLOGY; PHYSIOLOGY; SCIATIC NERVE; SPINAL CORD; SPRAGUE DAWLEY RAT;

ANIMALS; BIOLOGICAL ASSAY; BRAIN; CELL LINE; CEREBRAL VENTRICLES; ELECTRIC STIMULATION; HEAT; HIPPOCAMPUS; INFUSIONS, PARENTERAL; MALE; NEURITIS; NOREPINEPHRINE; PAIN THRESHOLD; RATS; RATS, SPRAGUE-DAWLEY; SCIATIC NERVE; SPINAL CORD; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033546760     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)01782-5     Document Type: Article

References (33)

1. 2-adrenoceptor mediated hyperpolarization of locus coeruleus neurons: intracellular studies in vivo. Science. 215:1982;1394-1396.
2. Bennett G.J., Xie Y.-K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain. 33:1988;87-107.
3. Bianchi M., Sacerdote P., Ricciardi-Castagnoli P., Mantegazza P., Panerai A. Central effects of tumor necrosis factor alpha and interleukin-1 alpha on nociceptive thresholds and spontaneous locomotor activity. Neuroscience Letters. 148:1992;76-80.
4. Bryson H.M., Wilde M.I. Amitriptyline: a review of its pharmacological properties and therapeutic use in chronic pain states. Drugs and Aging. 8:1996;459-476.
5. Clark F.M., Proudfit H.K. The projection of locus coeruleus neurons to the spinal cord in the rat determined by anterograde tracing combined with immunocytochemistry. Brain Res. 538:1991;231-245.
6. Codd E.E., Press J.B., Raffa R.B. Alpha-2 adrenoceptors vs. imidazoline receptors: implications for alpha-2 mediated analgesia and other non-cardiovascular therapeutic uses, [Review]. Life Sciences. 56:1995;63-74.
7. Deleo J.A., Colburn R.W., Rickman A.J. Cytokine and growth factor immunohistochemical spinal profiles in two animal models of mononeuropathy. Brain Res. 759:1997;50-57.
8. Dubner R., Ruda M.A. Activity-dependent neuronal plasticity following tissue injury and inflammation. Trends Neurol. Sci. 15:1992;96-103.
9. Ferreira S.H. The role of interleukins and nitric oxide in the mediation of inflammatory pain and its control by peripherial analgesics, [Review]. Drugs. 46(1):1993;1-9. Suppl.
10. Foreback J.L., Remick D.G., Crockett-Torabi E., Ward P.A. Cytokine responses of human blood monocytes stimulated with Igs. Inflammation. 21:1997;501-517.
11. Fukuoka H., Kawatani M., Hisamitsu T., Takeshige C. Cutaneous hyperalgesia induced by peripheral injection of interleukin-1 beta in the rat. Brain Res. 657:1994;133-140.
12. Ignatowski T.A., Spengler R.N. Tumor necrosis factor-α: presynaptic sensitivity is modified after antidepressant drug administration. Brain Res. 665:1994;293-299.
13. Ignatowski T.A., Chou R.C., Spengler R.N. Changes in noradrenergic sensitivity to tumor necrosis factor-α in brains of rats administered clonidine. J. Neuroimmunol. 70:1996;55-63.
14. Ignatowski T.A., Noble B.K., Wright J.R., Gorfien J.L., Heffner R.R., Spengler R.N. Neuronal-associated tumor necrosis factor (TNFα): its role in noradrenergic functioning and modification of its expression following antidepressant drug administration. J. Neuroimmunol. 79:1997;84-90.
15. Khabar K.S.A., Siddiqui S., Armstrong J.A. WEHI-13VAR: a stable and sensitive variant of WEHI 164 clone 13 fibrosarcoma for tumor necrosis factor bioassay. Immunol. Lett. 46:1995;107-110.
16. Khanna S., Sinclair J.G. Noxious stimuli produce prolonged changes in the CA1 region of the rat hippocampus. Pain. 39:1989;337-343.
17. Margalit D., Segal M. A pharmacologic study of analgesia produced by stimulation of the nucleus locus coeruleus. Psychopharmacology. 62:1979;169-173.
18. Mittelman A., Puccio C., Gafney E., Coombe N., Singh B., Wood D., Nadler P., Ahmed T., Arlin Z. A phase I pharmacokinetic study of recombinant human TNF administered by a 5-day continuous infusion. Investigational New Drugs. 10:1992;183-190.
19. Moore R.Y., Bloom F.E. Central catecholamine neuron systems: anatomy and physiology of the norepinephrine and epinephrine systems. Annu. Rev. Neuroscience. 2:1979;113-168.
20. Oka T., Wakugawa Y., Hosoi M., Oka K., Hori T. Intracerebroventricular injection of tumor necrosis factor-alpha induces thermal hyperalgesia in rats. Neuroimmunomodulation. 3:1996;135-140.
21. Proudfit H.K. Pharmacological evidence for the modulation of nociception by noradrenergic neurons. Prog. Brain Res. 77:1998;357-370.
22. Rankin E.C., Choy E.H., Kassimos D., Kingsley G.H., Sopwith A.M., Isenberg D.A., Panayi G.S. The therapeutic effects of an engineered human anti-tumor necrosis factor alpha antibody (CDP571) in rheumatoid arthritis. Br. J. Rheumatol. 34:1995;334-342.
23. Sommer C., Marziniak M., Myers R.R. The effect of thalidomide treatment on vascular pathology and hyperalgesia caused by chronic constriction injury of rat nerve. Pain. 74:1998;83-91.
24. Spengler R.N., Chensue S.W., Giacherio D.A., Blenk N., Kunkel S.L. Endogenous norepinephrine regulates tumor necrosis factor-alpha production from macrophages in vitro. J. Immunol. 152:1994;3024-3031.
25. Starke K., Gothert M., Kilbinger H. Modulation of neurotransmitter release by presynaptic autoreceptors. Physiol. Rev. 69:1989;864-989.
26. Swanson L.W., Hartman B.K. The central adrenergic system. An immunofluorescence study of the location of cell bodies and their efferent connections in the rat utilizing dopamine-beta-hydroxylase as a marker. J. Comp. Neurol. 163:1975;467-505.
27. Ueda Y., Lee K.H., Ito S., Saito K., Niesen N., Brentjens J.R., Gans R.O.B. In vivo neutralization of tumor necrosis factor attenuates the generalized Shwartzman reaction in the rabbit. J. Endotoxin Res. 3:1996;67-75.
28. Wagner R., Myers R.R. Endoneurial injection of TNF-alpha produces neuropathic pain behaviors. NeuroReport. 7:1996;2897-2901.
29. Wakisaka S., Kajander K.C., Bennett G.J. Abnormal skin temperature and abnormal sympathetic vasomotor innervation in an experimental painful peripheral neuropathy. Pain. 46:1991;299-313.
30. Watkins L.R., Wiertelak E.P., Goehler L.E., Smith K.P., Martin D., Maier S.F. Characterization of cytokine-induced hyperalgesia. Brain Res. 654:1994;15-26.
31. Watkins L.R., Goehler L.E., Relton J., Brewer M.T., Maier S.F. Mechanisms of tumor necrosis factor-alpha (TNF-alpha) hyperalgesia. Brain Res. 692:1995;244-250.
32. Watkins L.R., Maier S.F., Goehler L.E. Immune activation: the role of proinflammatory cytokines in inflammation, illness responses and pathological pain states. Pain. 63:1995;289-302.
33. White J.D., Schwartz M.W. Using osmotic minipumps for intracranial delivery of amino acids and peptides. Methods Neurosci. 21:1994;187-200.